Our previous findings reported an increased expression of CECR1 in TAMs of gliomas, and provided causal evidence that CECR1 is vital for promoting TAM differentiation towards a M2-like (immune-suppressive) phenotype [23]. This evidence concerns the gene ADA2 and glioma.